‘Right shoring’ API production in Europe
Pharmaceutical Technology
MARCH 22, 2023
In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The energy-related slowdown in manufacturing will aggravate the ongoing drug shortages in Europe.”
Let's personalize your content